Desai, A. S., Swedberg, K., Mcmurray, J. J. V., Granger, C. B., Yusut, S., Young, J. B., … Pfeffer, M. A. (2006). Incidence and predictors of hyperkalemia in patients with heart failure - An analysis of the candesartan in heart failure - Assessment of reduction in mortality and morbidity (CHARM) program. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 47, pp. 52A-52A).

Desai, A. S., K. Swedberg, J. J. V. Mcmurray, C. B. Granger, S. Yusut, J. B. Young, M. E. Dunlap, et al. “Incidence and predictors of hyperkalemia in patients with heart failure - An analysis of the candesartan in heart failure - Assessment of reduction in mortality and morbidity (CHARM) program.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 47:52A-52A, 2006.

Desai AS, Swedberg K, Mcmurray JJV, Granger CB, Yusut S, Young JB, et al. Incidence and predictors of hyperkalemia in patients with heart failure - An analysis of the candesartan in heart failure - Assessment of reduction in mortality and morbidity (CHARM) program. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2006. p. 52A-52A.

Desai, A. S., et al. “Incidence and predictors of hyperkalemia in patients with heart failure - An analysis of the candesartan in heart failure - Assessment of reduction in mortality and morbidity (CHARM) program.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 47, no. 4, 2006, pp. 52A-52A.

Desai AS, Swedberg K, Mcmurray JJV, Granger CB, Yusut S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olotsson B, Michelson EL, Pfeffer MA. Incidence and predictors of hyperkalemia in patients with heart failure - An analysis of the candesartan in heart failure - Assessment of reduction in mortality and morbidity (CHARM) program. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2006. p. 52A-52A.